Atherosclerosis Plus, formerly ‘Atherosclerosis Supplements’, is an open access journal, Editor-in-Chief Prof Laura Calabresi from University of Milano, Italy.
Atherosclerosis Plus publishes both original research and review papers that address the key aspects of atherosclerosis, including its pathogenesis and genetic basis, its risk factors (e.g. dyslipidemia and lipid related disorders, hypertension, obesity, diabetes), and the impact of lifestyle modifications (e.g., smoking, diet, physical activity) and nutritional and pharmacological interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions.
Types of papers that can be submitted for consideration by the Editorial Board include Original Research Papers, Brief Communications, Case Reports, and Review Articles. The journal periodically publishes special theme issues devoted to areas of current interest.
Key points of the journal are the high standard of papers obtained through a rigorous peer review process, and the wide dissemination of findings allowed by the open access policy. The journal is indexed in the Directory of Open Access Journal (DOAJ), Scopus, and Clarivate.